|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 21
2022
Ristau, J.; Hoerner-Rieber, J.; Buchele, C.; Klueter, S.; Jaekel, C.; Baumann, L.; Andratschke, N.; Schueler, H. Garcia; Guckenberger, M.; Li, M.; Niyazi, M.; Belka, C.; Herfarth, K.; Debus, J. und Koerber, S. A.
(2022):
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial.
In: Radiation Oncology, Bd. 17, Nr. 1, 75
Hoegen, P.; Zhang, K. S.; Tonndorf-Martini, E.; Weykamp, F.; Regnery, S.; Naumann, P.; Lang, K.; Ristau, J.; Koerber, S. A.; Dreher, C.; Buchele, C.; Rippke, C.; Renkamp, C. K.; Paul, K. M.; Koenig, L.; Buesch, C.; Krisam, J.; Sedlaczek, O.; Schlemmer, H.-P.; Niyazi, M.; Corradini, S.; Debus, J.; Klueter, S. und Hoerner-Rieber, J.
(2022):
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
In: Radiation Oncology, Bd. 17, Nr. 1, 59
Bodensohn, R.; Forbrig, R. 
ORCID: https://orcid.org/0000-0002-1054-1463; Quach, S.; Reis, J.; Boulesteix, A.-L. ORCID: https://orcid.org/0000-0002-2729-0947; Mansmann, Ulrich ORCID: https://orcid.org/0000-0002-9955-8906; Hadi, I.; Fleischmann, D.F.; Mücke, J.; Holzgreve, A.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Ruf, V.; Dorostkar, M.; Corradini, S.; Herms, J.; Belka, C. ORCID: https://orcid.org/0000-0002-1287-7825; Thon, N. und Niyazi, M. ORCID: https://orcid.org/0000-0002-7711-9486
(2022):
MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy.
In: ESMO Open, Bd. 7, Nr. 2, 100424
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-1054-1463; Quach, S.; Reis, J.; Boulesteix, A.-L. ORCID: https://orcid.org/0000-0002-2729-0947; Mansmann, Ulrich ORCID: https://orcid.org/0000-0002-9955-8906; Hadi, I.; Fleischmann, D.F.; Mücke, J.; Holzgreve, A.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Ruf, V.; Dorostkar, M.; Corradini, S.; Herms, J.; Belka, C. ORCID: https://orcid.org/0000-0002-1287-7825; Thon, N. und Niyazi, M. ORCID: https://orcid.org/0000-0002-7711-9486
(2022):
MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy.
In: ESMO Open, Bd. 7, Nr. 2, 100424
[PDF, 1MB]
Pavic, M. ORCID: https://orcid.org/0000-0002-3899-6152; Niyazi, M. ORCID: https://orcid.org/0000-0002-7711-9486; Wilke, L.; Corradini, S.; Vornhülz, M.; Mansmann, U. ORCID: https://orcid.org/0000-0002-9955-8906; Al Tawil, A.; Fritsch, R.; Hörner-Rieber, J.; Debus, J.; Guckenberger, M.; Belka, C. ORCID: https://orcid.org/0000-0002-1287-7825; Mayerle, J. und Beyer, G.
(2022):
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
In: Radiation Oncology, Bd. 17, 18
[PDF, 814kB]
ORCID: https://orcid.org/0000-0002-3899-6152; Niyazi, M. ORCID: https://orcid.org/0000-0002-7711-9486; Wilke, L.; Corradini, S.; Vornhülz, M.; Mansmann, U. ORCID: https://orcid.org/0000-0002-9955-8906; Al Tawil, A.; Fritsch, R.; Hörner-Rieber, J.; Debus, J.; Guckenberger, M.; Belka, C. ORCID: https://orcid.org/0000-0002-1287-7825; Mayerle, J. und Beyer, G.
(2022):
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
In: Radiation Oncology, Bd. 17, 18
[PDF, 814kB]
2021
Ostheimer, C.; Maeurer, M.; Ebert, N.; Schmitt, D.; Krug, D.; Baumann, R.; Henkenberens, C.; Giordano, F. A.; Sautter, L.; Lopez, Guerra; Fleischmann, D. F.; Niyazi, M.; Kasmann, L.; Kaul, D.; Thieme, A. H.; Billiet, C.; Dobiasch, S.; Arnold, C. R.; Oertel, M.; Haussmann, J.; Gauer, T.; Goy, Y.; Suess, C.; Ziegler, S.; Panje, C. M.; Baues, C.; Trommer-Nestler, M.; Skripcak, T. und Medenwald, D.
(2021):
Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group.
In: Strahlentherapie und Onkologie, Bd. 197, Nr. 5: S. 385-395
2020
Unterrainer, M.; Eze, C.; Ilhan, H.; Marschner, S.; Roengvoraphoj, O.; Schmidt-Hegemann, N. S.; Walter, F.; Kunz, W. G.; Munck af Rosenschold, P.; Jeraj, R.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Grosu, A. L.; Niyazi, M.; Bartenstein, P. und Belka, C.
(2020):
Recent advances of PET imaging in clinical radiation oncology.
In: Radiation Oncology, Bd. 15, Nr. 1, 88
ORCID: https://orcid.org/0000-0003-0953-7624; Grosu, A. L.; Niyazi, M.; Bartenstein, P. und Belka, C.
(2020):
Recent advances of PET imaging in clinical radiation oncology.
In: Radiation Oncology, Bd. 15, Nr. 1, 88
2019
Bodensohn, R.; Hadi, I; Fleischmann, D. F.; Corradini, S.; Thon, N.; Rauch, J.; Belka, C. und Niyazi, M.
(2019):
Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis.
In: Strahlentherapie und Onkologie, Bd. 196, Nr. 1: S. 70-76
Unterrainer, Marcus; Fleischmann, D. F.; Diekmann, C.; Vomacka, L.; Lindner, S.; Vettermann, F.; Brendel, M.; Wenter, V.; Ertl-Wagner, B.; Herms, J.; Wetzel, C.; Rupprecht, R.; Tonn, J. C.; Belka, C.; Bartenstein, P.; Niyazi, M. und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Comparison of F-18-GE-180 and dynamic F-18-FET PET in high grade glioma: a double-tracer pilot study.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 46, Nr. 3: S. 580-590
ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Comparison of F-18-GE-180 and dynamic F-18-FET PET in high grade glioma: a double-tracer pilot study.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 46, Nr. 3: S. 580-590
Unterrainer, M.; Niyazi, M.; Tonn, J. C.; Ilhan, H.; Bartenstein, P. und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Current status of SSR-directed imaging and therapy in meningioma.
In: Clinical and Translational Imaging, Bd. 7, Nr. 3: S. 171-180
ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Current status of SSR-directed imaging and therapy in meningioma.
In: Clinical and Translational Imaging, Bd. 7, Nr. 3: S. 171-180
Corradini, S.; Alongi, F.; Andratschke, N.; Belka, C.; Boldrini, L.; Cellini, F.; Debus, J.; Guckenberger, M.; Hoerner-Rieber, J.; Lagerwaard, F. J.; Mazzola, R.; Palacios, M. A.; Philippens, M. E. P.; Raaijmakers, C. P. J.; Terhaard, C. H. J.; Valentini, V. und Niyazi, M.
(2019):
MR-guidance in clinical reality: current treatment challenges and future perspectives.
In: Radiation Oncology, Bd. 14, 92
Unterrainer, M.; Niyazi, M.; Tonn, J. C.; Ilhan, H.; Bartenstein, P. und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
A look ahead: future directions of SSR-directed imaging and therapy in meningioma.
In: Clinical and Translational Imaging, Bd. 7, Nr. 5: S. 357-362
ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
A look ahead: future directions of SSR-directed imaging and therapy in meningioma.
In: Clinical and Translational Imaging, Bd. 7, Nr. 5: S. 357-362
2018
Dietzel, C. T.; Jablonska, K.; Niyazi, M.; Gauer, T.; Ebert, N.; Ostheimer, C. und Krug, D.
(2018):
Quality of training in radiation oncology in Germany: where do we stand? Results from a 2016/2017 survey performed by the working group "young DEGRO" of the German society of radiation oncology (DEGRO).
In: Strahlentherapie und Onkologie, Bd. 194, Nr. 4: S. 293-302
2017
Niyazi, M.; Ruf, V; Fleischmann, D.; Piehlmaier, D.; Mittelbronn, M.; Giese, A.; Zitzelsberger, H.; Belka, C. und Unger, K.
(2017):
Independent validation of a prognostic 4-miRNA signature in de novo glioblastoma.
In: Strahlentherapie und Onkologie, Bd. 193:
S52-S52
Hadi, I; Roengvoraphoj, O.; Niyazi, M.; Röder, F.; Belka, C. und Nachbichler, S.
(2017):
Medulloblastoma in adults: A retrospective single institution analysis.
In: Strahlentherapie und Onkologie, Bd. 193:
S158-S158
Piehlmaier, D.; Stegen, B.; Nieto, A.; Orth, M.; Niyazi, M.; Ruf, V; Hess, J.; Zitzelsberger, H.; Lauber, K. und Unger, K.
(2017):
In-vitro and in-vivo characterization of a glioblastoma cell line panel.
In: Strahlentherapie und Onkologie, Bd. 193:
S154-S154
Reitz, D.; Schönecker, S.; Freislederer, P.; Escudero, Pazos M.; Niyazi, M.; Ganswindt, U.; Belka, C. und Corradini, S.
(2017):
Intrafraktionelle Bewegung bei der Strahlentherapie von Brustkrebs: Analyse von 629 Fraktione.
In: Strahlentherapie und Onkologie, Bd. 193:
S141-S141
Walter, F.; Jell, C.; Ilhan, H.; Belka, C.; Niyazi, M.; Jensen, A. D. und Falk, R.
(2017):
Anwendbarkeit semiautomatischer PET-Konturierung anhand des biologischen Tumorvolumens zur Zielvolumendefinition beim Ösophaguskarzinom.
In: Strahlentherapie und Onkologie, Bd. 193:
S174-S175
Zollner, B. D.; Ganswindt, U.; Maihöfer, C.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Belka, C. und Niyazi, M.
(2017):
Rezidivmusteranalyse nach Bestrahlung von high-grade Meningeomen.
In: Strahlentherapie und Onkologie, Bd. 193:
S161-S161
ORCID: https://orcid.org/0000-0003-0953-7624; Belka, C. und Niyazi, M.
(2017):
Rezidivmusteranalyse nach Bestrahlung von high-grade Meningeomen.
In: Strahlentherapie und Onkologie, Bd. 193:
S161-S161
Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Unterrainer, M.; Fleischmann, D. F.; Lindner, S.; Vettermann, F.; Brunegraf, A.; Vomacka, L.; Brendel, M.; Wenter, V.; Wetzel, C.; Rupprecht, R.; Tonn, J.-C.; Belka, C.; Bartenstein, P. und Niyazi, M.
(2017):
TSPO PET for glioma imaging using the novel ligand F-18-GE-180: first results in patients with glioblastoma.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 44, Nr. 13: S. 2230-2238
ORCID: https://orcid.org/0000-0003-0953-7624; Unterrainer, M.; Fleischmann, D. F.; Lindner, S.; Vettermann, F.; Brunegraf, A.; Vomacka, L.; Brendel, M.; Wenter, V.; Wetzel, C.; Rupprecht, R.; Tonn, J.-C.; Belka, C.; Bartenstein, P. und Niyazi, M.
(2017):
TSPO PET for glioma imaging using the novel ligand F-18-GE-180: first results in patients with glioblastoma.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 44, Nr. 13: S. 2230-2238
Zollner, B. D.; Vettermann, F.; Ilhan, H.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Ganswindt, U.; Belka, C. und Niyazi, M.
(2017):
[68Ga]DOTATATE-PET-basierte Zielvolumendefinition bei Meningeomen WHO Grad I.
In: Strahlentherapie und Onkologie, Bd. 193:
S152-S152
ORCID: https://orcid.org/0000-0003-0953-7624; Ganswindt, U.; Belka, C. und Niyazi, M.
(2017):
[68Ga]DOTATATE-PET-basierte Zielvolumendefinition bei Meningeomen WHO Grad I.
In: Strahlentherapie und Onkologie, Bd. 193:
S152-S152
2015
Corradini, S.; Niyazi, M.; Niemoeller, O. M.; Li, M.; Roeder, F.; Eckel, Renate; Schubert-Fritschle, Gabriele; Scheithauer, H. R.; Harbeck, N.; Engel, Jutta und Belka, Claus
(2015):
Adjuvant radiotherapy after breast conserving surgery - a comparative effectiveness research study.
In: Radiotherapy and Oncology, Bd. 114, Nr. 1: S. 28-34